Atherosclerosis Research Unit, Department of Southern California, Los Angeles, CA.
Department of Preventive Medicine, University of Southern California, Los Angeles, CA.
Menopause. 2020 May;27(5):512-518. doi: 10.1097/GME.0000000000001508.
Vasomotor flushing (hot flushes) is a common menopausal symptom experienced by most women going through the menopausal transition; flushing continues for a variable period in postmenopause. Primarily due to lack of ovarian estrogen, other biomarkers of hot flushes have not been clearly identified. We examined the relationship of hot flushes with ghrelin and adipokines.
Baseline data from two clinical trials, the Women's Isoflavone Soy Health (WISH) trial and Early versus Late Intervention Trial of Estrogen (ELITE), were used in this post hoc cross-sectional study. Both WISH and ELITE had similar study designs, inclusion criteria, and data collection processes. Study participants were healthy postmenopausal women not taking estrogen-based hormone therapy, free of cardiovascular disease, or any other chronic diseases. Both trials used the same hot flush diary in which participants recorded the number of daily hot flushes by severity over a month on average. Serum concentrations of ghrelin, leptin, adiponectin, and resistin were assessed in stored fasting blood samples using highly specific radioimmunoassay. In this analysis, self-reported flushing experience was tested for an association with leptin, adiponectin, resistin, and ghrelin concentrations using logistic regression and mean comparisons.
A total of 898 postmenopausal women from the ELITE and WISH trials contributed to this analysis. Mean (SD) age was 60.4 (7.0) years, body mass index (BMI) 27 (5.3) kg/m, 67% were white, and 47% were within 10 years of menopause. Reported flushing was significantly associated with younger age, lower education, lower BMI, being married, and more recent menopause. Adjusted for these factors other than BMI, women in the highest quartile of ghrelin had significantly greater likelihood of experiencing hot flushes (OR [95% CI] = 1.84 [1.21-2.85]) compared to women in the lowest quartile. The association was more pronounced among overweight or obese women (OR [95% CI] = 2.36 [1.28-4.35]) compared to those with normal BMI (1.24 [0.54, 2.86]; interaction P value = 0.46). The association between ghrelin and hot flushes was similar among early (within 10 y) and late (over 10 y) postmenopausal women. Blood levels of adiponectin and resistin were not associated with hot flushes.
Higher concentrations of ghrelin were associated with greater likelihood of hot flushes in both early- and late-postmenopausal women. Leptin, adiponectin, and resistin levels were not associated with hot flushes in postmenopausal women.
血管舒缩性潮红(热潮红)是大多数处于绝经期过渡阶段的女性常见的绝经症状;潮红在绝经后会持续一段时间。主要由于缺乏卵巢雌激素,其他热潮红的生物标志物尚未明确确定。我们研究了热潮红与胃饥饿素和脂肪因子的关系。
本研究使用了两项临床试验(妇女异黄酮大豆健康研究[WISH]试验和雌激素早期与晚期干预试验[ELITE])的基线数据。WISH 和 ELITE 具有相似的研究设计、纳入标准和数据收集过程。研究参与者为不服用基于雌激素的激素治疗的健康绝经后妇女,无心血管疾病或任何其他慢性疾病。两项试验均使用相同的热潮红日记,参与者在一个月内平均按严重程度记录每日热潮红的次数。使用高度特异性放射免疫测定法评估储存的空腹血样中的胃饥饿素、瘦素、脂联素和抵抗素浓度。在这项分析中,使用逻辑回归和均值比较来测试自我报告的潮红体验与瘦素、脂联素、抵抗素和胃饥饿素浓度之间的关联。
来自 ELITE 和 WISH 试验的 898 名绝经后妇女参与了这项分析。平均(SD)年龄为 60.4(7.0)岁,体重指数(BMI)为 27(5.3)kg/m,67%为白人,47%处于绝经后 10 年内。报告的潮红与较年轻、较低的教育程度、较低的 BMI、已婚和绝经较近显著相关。在调整 BMI 以外的这些因素后,胃饥饿素最高四分位数的女性发生热潮红的可能性显著更高(比值比[95%CI] = 1.84[1.21-2.85]),与胃饥饿素最低四分位数的女性相比。在超重或肥胖的女性中(比值比[95%CI] = 2.36[1.28-4.35])与 BMI 正常的女性(1.24[0.54, 2.86])相比,这种关联更为明显(交互 P 值=0.46)。在绝经早期(10 年内)和晚期(超过 10 年)的女性中,胃饥饿素与热潮红之间的关联相似。脂联素和抵抗素的血液水平与热潮红无关。
较高的胃饥饿素浓度与绝经后早期和晚期女性热潮红的可能性增加相关。瘦素、脂联素和抵抗素水平与绝经后妇女的热潮红无关。